Treating Advanced Unresectable or Metastatic HER2-Positive Breast Cancer: A Spotlight on Tucatinib. Ulrich L, Okines AFC. Breast Cancer (Dove Med Press) 2021;13:361-381.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ulrich L, Okines AFC. Treating Advanced Unresectable or Metastatic HER2-Positive Breast Cancer: A Spotlight on Tucatinib. Breast Cancer (Dove Med Press) 2021;13:361-381.
PMID: 34079368